AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2020 Issue 4; Section X-New Technology
Measurement of Infection
Two new codes have been created at table XXE, New Technology, Physiological Systems, Measurement, with the Device/Substance/Technology values noted below. Device/Substance/Technology N Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility Q Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection Positive Blood Culture Fluorescence Hybridization Code XXE5XN6, Measurement of infection, positive blood culture fluorescence hybridization for organism identification, concentration and susceptibility, new technology group 6, was created to describe the processing and analysis of a positive blood culture using the Accelerate PhenoTest™ BC kit. The test is a fast, automated, phenotypic, direct-from-positive blood culture identification and...
Subscribe or sign in to view the full article.
Article Overview
This article covers newly created ICD-10-PCS measurement codes tied to infection-focused diagnostic technologies. It describes the broad clinical and laboratory context for these additions, including bloodstream infection testing and respiratory panel testing, and notes the organizations, platforms, and specimen types involved. The content is relevant to coding professionals, CDI staff, and healthcare organizations tracking new technology code updates.
Why This Topic Matters
These code additions reflect evolving diagnostic methods used in infectious disease testing and can affect facility coding, reporting, and technology tracking. Understanding the scope of the new codes helps stakeholders recognize when these new technology measurement categories are being discussed in a clinical or coding context.
Article Sections
-
Device/Substance/Technology
This section introduces the device and substance/technology values associated with the new measurement codes and frames the update within infection-related diagnostic testing.
-
Positive Blood Culture Fluorescence Hybridization
This section discusses the blood culture diagnostic technology, the laboratory methods used, and the general type of information the test is intended to provide.
-
Nucleic Acid-base Microbial Detection
This section describes the lower respiratory fluid testing technology, the specimen context, and the broader categories of organisms and targets addressed by the panel.
What You Will Learn
- Which broad infection-related diagnostic areas are covered by the article.
- How the article frames the newly added measurement code updates within new technology reporting.
- What general laboratory testing contexts are associated with the new blood culture and respiratory diagnostic technologies.
- Which clinical and laboratory stakeholders may be interested in these code additions.
Who Should Read This
- Hospital coders
- Clinical documentation specialists
- Revenue integrity professionals
- Health information management teams
- Laboratory and diagnostics stakeholders
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com